Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Small animal imaging involves devices and reagents used for preclinical imaging of rats and mice for the development of drugs, developmental studies, gene expression, and various other research activities. These devices are similar to imaging modalities used for diagnostic purposes in humans, however due to the smaller size are generally referred as micro devices.
The global small animal imaging market is estimated to account for US$ 4,879.3 Mn in terms of value by the end of 2027.
Global Small Animal Imaging Market: Drivers
Growing applications of preclinical imaging modalities in drug discovery and biotechnology research is expected to propel growth of the global small animal imaging market over the forecast period. Preclinical imaging is currently one of the most powerful and clinically translatable methods for monitoring disease progression. Early image-based indications from preclinical studies are being increasingly used for effective enrollment of patients or switching of treatment paradigm, which eventually saves time and money with respect to bringing novel drugs in the market. Drug manufacturers and biotechnology companies over a decade have substantially increased their focus on imaging endpoints in clinical trials, especially with techniques such as micro-MRI, Micro-PET and optical imaging. These inclinations have created a need for preclinical imaging tools and reagents for validating and optimizing imaging protocol pertaining to a specific agent or class of agent.
Moreover, exponential growth and demand for CROs in emerging market is also expected to aid in growth of the global small animal imaging market. Asia Pacific is gradually emerging as a prime destination for pharmaceutical research outsourcing due to lower operating costs and availability of skilled labor. This has resulted in the emergence of large number of contract research organizations (CROs) in this region.
North America held dominant position in the global small animal imaging market in 2019, accounting for 37.7% share in terms of volume, followed by Europe and Asia Pacific, respectively.
Figure 1: Global Small Animal Imaging Market Share (%) Value, By Region, 2019
Global Small Animal Imaging Market: Restraints
Despite the effectiveness of preclinical imaging systems to provide high quality and detailed images of small animals, high cost of preclinical imaging instruments is expected to hinder growth of the global small animal imaging market. For instance, a micro-PET system costs between US$ 400,000 and US$ 1,200,000 based on the system configuration and brand.
Moreover, stringent regulatory scenario is also expected to limit growth of the global small animal imaging market. For instance, clinical viability of molecular imaging devices require regulatory approval for imaging probes by the U.S. FDA and reimbursement from insurance carriers and the Centers for Medicare and Medicaid Services (CMS). This makes the overall approval process long, complicated and expensive, as the molecular imaging devices have a myriad of probes and technologies associated, all seeking prerequisite approval and reimbursement before actual launch.
Small Animal Imaging Market Report Coverage
||Market Size in 2020:
||US$ 2,740.0 Mn
|Historical Data for:
||2016 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 4,879.3 Mn
- North America: U.S., Canada
- Latin America: Brazil, Argentina, Mexico, Rest of Latin America
- Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
- Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
- Middle East: GCC Countries, Israel, Rest of Middle East
- Africa: North Africa, Central Africa, South Africa
- By Product Type:
- Devices: CT, MRI, PET/SPECT, Multimodal, Optical Imaging, Ultrasound, PAT.
- By Application: Oncology, Cardiology, Autoimmune diseases, Neurology and Psychiatry, Others.
Agilent Technologies, Inc., Aspect Imaging, Bruker Corporation, TriFoil Imaging, Inc., LI-COR Biosciences, Inc., FujiFilm VisualSonics, Inc., Miltenyi Biotec GmbH, MR Solutions, Perkin Elmer, Inc., Promega Corporation, Siemens AG, AXT, Hallmarq Veterinary Imaging, and SCANCO Medical AG
- Approval and launch of new products
|Restraints & Challenges:
- Stringent Regulatory Scenario
Global Small Animal Imaging Market: Opportunities
Investment R&D in novel reagents is expected to offer lucrative growth opportunities for players in the global small animal imaging market. Development of reagents which either have superior imaging results or potential to be used in multiple devices will help companies to retain market share for a considerably longer period.
Moreover, R&D in animal imaging is also expected to aid in growth of the global small animal imaging market. For instance, in June 2020, researchers from Institute of Biological and Medical Imaging (IBMI), Germany, reported development of two photochromic proteins for cell-specific in vivo optoacoustic whole-animal imaging with signal unmixing in the temporal domain.
The global small animal imaging market was valued at US$ 2,562.3 Mn in 2019 and is forecast to reach a value of US$ 4,879.3 Mn by 2027 at a CAGR of 8.6% between 2020 and 2027.
Figure 2: Global Small Animal Imaging Market Value (US$ Mn), 2016 – 2027
Market Trends/Key Takeaways
Major players in the global small animal imaging market are focused on launching new products to expand their product portfolio. For instance, in September 2020, AXT launched the Vieworks range of bio-imaging systems. The VISQUE bio-imaging range will be an asset to medical researchers working in Translational Research such as drug discovery, cancer research and many more applications.
Increasing adoption of small animal imaging products is expected to propel growth of the market. For instance, in May 2020, The USF Health Heart Institute acquired 7T PET/MR and PET/CT integrated imaging systems from MR Solutions for preclinical research.
Figure 3. Value Chain Analysis
Global Small Animal Imaging Market: Competitive Landscape
Major players operating in the global small animal imaging market include, Agilent Technologies, Inc., Aspect Imaging, Bruker Corporation, TriFoil Imaging, Inc., LI-COR Biosciences, Inc., FujiFilm VisualSonics, Inc., Miltenyi Biotec GmbH, MR Solutions, Perkin Elmer, Inc., Promega Corporation, Siemens AG, AXT, Hallmarq Veterinary Imaging, and SCANCO Medical AG.
Global Small Animal Imaging Market: Key Developments
Major players in the global small animal imaging market are focused on launching new products to expand their product portfolio. For instance, in September 2020, Hallmarq Veterinary Imaging launched a second-generation MRI system for large-breed dogs and other small animals.